EU Regulations: The Catastrophic Costs Of Failing To Be A Trailblazer
Executive Summary
Whatever the hurdles to compliance with the new EU Medical Device and IVD Regulations, procrastination will cost firms dearly, says Peter Rose, of compliance consulting firm Maetrics. In an interview with Medtech Insight, he stresses the urgency of quick action and calculates the cost to companies that are late to to comply.
You may also be interested in...
Impending Sense Of Regulatory Panic? EU's MDR/IVDR One Year On
It has been one year since the EU Medical Device and IVD Regulations took effect, leaving two years before the MDR fully applies and four before the IVDR fully applies. What has been achieved? And why is there a sense of panic among some in industry?
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.